Terms: = Bone cancer AND Neurokinin AND Treatment
8 results:
1. Impact of the Oncology Care Model on Use of Supportive Care Medications During cancer treatment.
Brooks GA; Landrum MB; Kapadia NS; Liu PH; Wolf R; Riedel LE; Hsu VD; Jhatakia Parekh S; Simon C; Hassol A; Keating NL
J Clin Oncol; 2022 Jun; 40(16):1763-1771. PubMed ID: 35213212
[TBL] [Abstract] [Full Text] [Related]
2. Efficacy and safety of multiple doses of NEPA without dexamethasone in preventing nausea and vomiting induced by multiple-day and high-dose chemotherapy in patients with non-Hodgkin's lymphoma undergoing autologous hematopoietic stem cell transplantation: a phase IIa, multicenter study.
Di Renzo N; Musso M; Scimè R; Cupri A; Perrone T; De Risi C; Pastore D; Guarini A; Mengarelli A; Benedetti F; Mazza P; Capria V; Chiusolo P; Cupelli L; Federico V; Bozzoli V; Messa AR; Codega P; Bonizzoni E; Specchia G
Bone Marrow Transplant; 2020 Nov; 55(11):2114-2120. PubMed ID: 32346078
[TBL] [Abstract] [Full Text] [Related]
3. Role of neurokinin 3 Receptor Signaling in Oral Squamous Cell Carcinoma.
Obata K; Shimo T; Okui T; Matsumoto K; Takada H; Takabatake K; Kunisada Y; Ibaragi S; Yoshioka N; Kishimoto K; Nagatsuka H; Sasaki A
Anticancer Res; 2017 Nov; 37(11):6119-6123. PubMed ID: 29061792
[TBL] [Abstract] [Full Text] [Related]
4. Aprepitant in adolescent patients for prevention of chemotherapy-induced nausea and vomiting: a randomized, double-blind, placebo-controlled study of efficacy and tolerability.
Gore L; Chawla S; Petrilli A; Hemenway M; Schissel D; Chua V; Carides AD; Taylor A; Devandry S; Valentine J; Evans JK; Oxenius B;
Pediatr Blood Cancer; 2009 Feb; 52(2):242-7. PubMed ID: 18985740
[TBL] [Abstract] [Full Text] [Related]
5. neurokinin receptors as potential targets in breast cancer treatment.
Reddy BY; Trzaska KA; Murthy RG; Navarro P; Rameshwar P
Curr Drug Discov Technol; 2008 Mar; 5(1):15-9. PubMed ID: 18537563
[TBL] [Abstract] [Full Text] [Related]
6. G-coupled protein receptors and breast cancer progression: potential drug targets.
Taborga M; Corcoran KE; Fernandes N; Ramkissoon SH; Rameshwar P
Mini Rev Med Chem; 2007 Mar; 7(3):245-51. PubMed ID: 17346217
[TBL] [Abstract] [Full Text] [Related]
7. Aprepitant: a neurokinin-1 receptor antagonist for the treatment of chemotherapy-induced nausea and vomiting.
Navari RM
Expert Rev Anticancer Ther; 2004 Oct; 4(5):715-24. PubMed ID: 15485308
[TBL] [Abstract] [Full Text] [Related]
8. Pathogenesis-based treatment of chemotherapy-induced nausea and vomiting--two new agents.
Navari RM
J Support Oncol; 2003; 1(2):89-103. PubMed ID: 15352652
[TBL] [Abstract] [Full Text] [Related]
